ARPA-H funded the development of personalized RNA therapies
The U.S. Advanced Research Projects Agency for Health, ARPA-H, has funded biotechnology companies working on personalized RNA therapies. This was reported by STAT News in an article published on September 2, 2026.
License for Roche
Roche received a license for a trispecific antibody. The publication also listed this event among the key news in the pharmaceutical and biotechnology industries.
More current news is available on the UA.News Telegram channel Telegram.
Drug pricing agreements
U.S. President Donald Trump presented new agreements with biopharmaceutical companies as part of his commitments to reduce drug costs. At the same time, STAT journalist John Wilkerson noted that these agreements may not produce significant results and could potentially weaken the administration’s own efforts to lower drug prices.
UniQure applications
UniQure submitted applications to the U.S. Food and Drug Administration and the British regulator MHRA. It is seeking authorization to sell AMT-130, a treatment for Huntington’s disease.
